Found: 5
Select item for more details and to access through your institution.
Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00648-0
- By:
- Publication type:
- Article
Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER combination therapy.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-021-00798-9
- By:
- Publication type:
- Article
New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 605, doi. 10.1007/s00432-020-03144-7
- By:
- Publication type:
- Article
Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Validation of an Optical Microplate Label-Free Platform in the Screening of Chemical Libraries for Direct Binding to a Nuclear Receptor.
- Published in:
- Assay & Drug Development Technologies, 2011, v. 9, n. 5, p. 532, doi. 10.1089/adt.2010.0345
- By:
- Publication type:
- Article